(Q37084085)

18 August 2017

1 reference

title

The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney (English)

1 reference

18 August 2017

1 reference

J A Phipps

1

1 reference

18 August 2017

E P Feener

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

13 February 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

73

1 reference

18 August 2017

issue

10

1 reference

18 August 2017

page(s)

1114-1119

1 reference

The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study

18 August 2017

cites work

1 reference

7 January 2021

Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity

1 reference

7 January 2021

Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor

1 reference

7 January 2021

Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury

1 reference

7 January 2021

Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury

1 reference

7 January 2021

Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy

1 reference

7 January 2021

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

1 reference

7 January 2021

Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma

1 reference

7 January 2021

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling

1 reference

7 January 2021

Formation of bradykinin: a major contributor to the innate inflammatory response

1 reference

7 January 2021

Expression and cellular localization of the kallikrein-kinin system in human ocular tissues

1 reference

7 January 2021

Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.

1 reference

7 January 2021

Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage

1 reference

7 January 2021

Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

1 reference

7 January 2021

Renal Kallikrein and Hemodynamic Abnormalities of Diabetic Kidney

1 reference

7 January 2021

The role of the renal kallikrein-kinin system in diabetic nephropathy

1 reference

7 January 2021

The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

1 reference

7 January 2021

Expression of kinin B(1) receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-kappa B.

1 reference

7 January 2021

Endothelium-Derived Relaxing Factors and Converting Enzyme Inhibition

1 reference

7 January 2021

A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation

1 reference

7 January 2021

Plasma bradykinin in angio-oedema.

1 reference

7 January 2021

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

1 reference

7 January 2021

1 reference

7 January 2021

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

1 reference

7 January 2021

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology

1 reference

7 January 2021

Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist

1 reference

7 January 2021

Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer

1 reference

7 January 2021

Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules.

1 reference

7 January 2021

Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.

1 reference

7 January 2021

Bradykinin-induced proinflammatory signaling mechanisms

1 reference

7 January 2021

Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells

1 reference

7 January 2021

Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo

1 reference

7 January 2021

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

7 January 2021

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

1 reference

7 January 2021

Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor

1 reference

7 January 2021

The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway

1 reference

7 January 2021

Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen

1 reference

7 January 2021

Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen

1 reference

7 January 2021

Targeting kinin B(1) receptor for therapeutic neovascularization

1 reference

7 January 2021

Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

1 reference

7 January 2021

Early upregulation of kinin B1 receptors in retinal microvessels of the streptozotocin-diabetic rat.

1 reference

7 January 2021

Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation

1 reference

7 January 2021

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

1 reference

7 January 2021

Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation

1 reference

7 January 2021

Identifiers

DOI

10.1038/KI.2008.9

1 reference

18 August 2017

1 reference